D
CRISPR Therapeutics AG CRSP
$41.86 $3.298.53% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -264.49% 56.59% 32.01% -8.42% -230.49%
Total Depreciation and Amortization -2.19% 2.17% -2.19% 0.25% -1.37%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 230.76% -53.63% -5.45% 40.57% -19.29%
Change in Net Operating Assets 325.21% 39.65% -484.71% -95.02% 203.19%
Cash from Operations -7.83% 53.20% -11.85% -187.09% 214.24%
Capital Expenditure 18.90% -15.98% 69.02% 1.94% 2.30%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -118.43% 165.73% -27.88% -30.00% -20.27%
Cash from Investing -118.67% 165.49% -27.34% -29.76% -20.07%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -37.26% 75.06% -- -- 685.68%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -37.26% 75.06% 2,168.67% -100.15% 685.68%
Foreign Exchange rate Adjustments 147.13% -216.00% 3,650.00% 118.18% -118.03%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -186.89% 128.05% -16.08% -170.14% 329.47%